225 related articles for article (PubMed ID: 27349317)
1. Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study.
Al-Dhohorah T; Mashrah M; Yao Z; Huang J
Eur J Histochem; 2016 Jun; 60(2):2629. PubMed ID: 27349317
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
4. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications.
Xiao X; Hu Y; Li C; Shi L; Liu W
Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Palani J; Lakshminarayanan V; Kannan R
Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
[TBL] [Abstract][Full Text] [Related]
8. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
11. Oral submucous fibrosis: A clinicopathological study of 674 cases in China.
Cai X; Yao Z; Liu G; Cui L; Li H; Huang J
J Oral Pathol Med; 2019 Apr; 48(4):321-325. PubMed ID: 30715767
[TBL] [Abstract][Full Text] [Related]
12. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
13. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
14. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
15. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
16. [Cell morphometric analysis in oral submucous fibrosis, leukoplakia and squamous cell carcinoma].
Gao S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 May; 27(3):145-7, 189. PubMed ID: 1292898
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between the quantity of oral mucosal micronucleus cells and cancerization].
Cao J; Liu HW; Liu XS; Jin JQ; Zhang P
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):600-2. PubMed ID: 21844976
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
[TBL] [Abstract][Full Text] [Related]
19. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
